Search Results - "Höer, A."

Impact of the Early Benefit Assessment on A Pharmaceutical's Real Consumption in Germany by Kotowa, W, Häussler, B, Reindl, S, Höer, A

Get full text

PND73 Multiple Sclerosis in Germany: Outpatient Health Care Patterns by Höer, A, Schiffhorst, G, Fischaleck, J, Gehrmann, L, Ahrens, H, Carl, G, Sigel, K.O, Osowski, U, Bleβ, H.H

Get full text

Healthcare utilization of back pain patients: results of a claims data analysis by Müller-Schwefe, G, Freytag, A, Höer, A, Schiffhorst, G, Becker, A, Casser, H-R, Glaeske, G, Thoma, R, Treede, R-D

“…The high life-time prevalence of chronic back pain (25-30% according to surveys in small samples) suggests that it may be a major source of healthcare cost and…”
Get more information

PCN291 - Regional Differences In Potential Savings For The Medical Treatment Of Advanced Prostate Cancer In The German Health Care System by de Millas, C, Höer, A

Get full text

Regional Differences In Potential Savings For The Medical Treatment Of Advanced Prostate Cancer In The German Health Care System by de Millas, C, Höer, A

“…OBJECTIVES: Gonadotropin-releasing hormone analogues (GnRH-analogues) are well established for treating advanced prostate cancer. In 2015 and 2016, four…”
Get full text

ANALYSIS OF HORMONE THERAPY PRESCRIPTION RATES BEFORE AND AFTER THE WHI STUDY USING CLAIMS DATA OF A GERMAN SICKNESS FUND by Gothe, H, Daroszewska, A, Höer, A, Glaeske, G, Häussler, B

Get full text

PNS144 HOW THE RESULTS OF THE AMNOG EARLY BENEFIT ASSESSMENT (EBA) IN GERMANY HAVE DEVELOPED OVER TIME by Reindl, S., Kotowa, W., Mathes, J., Höer, A.

Get full text

PHP35 - AMNOG EARLY BENEFIT ASSESSMENT (EBA) AND MARKET PENETRATION OF NEW DRUGS FOR MELANOMA, MULTIPLE SCLEROSIS AND DIABETES MELLITUS IN GERMANY by Mathes, J., Höer, A.

Get full text

Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation by Seifert, R, Höer, A, Schwaner, I, Buschauer, A

“…Histamine H1 receptors mediate activation of phospholipase C, with subsequent increases in cytosolic Ca2+ concentration ([Ca2+]i), and H2 receptors mediate…”
Get more information

Persistence and adherence with antihypertensive drug therapy in a German sickness fund population by HOER, A, GOTHE, H, KHAN, Z. M, SCHIFFHORST, G, VINCZE, G, HÄUSSLER, B

Get full text

PHP53 - Is The Proof of an Additional Benefit under amnog in Germany More Difficult for Certain Drugs than for Other Ones? by Kotowa, W, Reindl, S, Mathes, J, Doyno, T, Höer, A

Get full text

Is The Proof of an Additional Benefit under amnog in Germany More Difficult for Certain Drugs than for Other Ones? by Kotowa, W, Reindl, S, Mathes, J, Doyno, T, Höer, A

Get full text

PRS28 - Effect of CVD on COPD Related Resource Utilization and Direct Medical Costs Among Statutory Heatlh Insured Patients In Germany by Kip, M, Herth, F, Höer, A, Torka, S, Schiffhorst, G, Bless, H

Get full text

Effect of CVD on COPD Related Resource Utilization and Direct Medical Costs Among Statutory Heatlh Insured Patients In Germany by Kip, M, Herth, F, Höer, A, Torka, S, Schiffhorst, G, Bless, H

Get full text

PHP71 - Impact of the Early Benefit Assessment on A Pharmaceutical's Real Consumption in Germany by Kotowa, W., Häussler, B., Reindl, S., Höer, A.

Get full text

Signaling effects of α-thrombin and SFLLRN in rat glioma C6 cells by Kaufmann, R., Lindschau, C., Höer, A., Henklein, P., Adomeit, A., Haller, H., Liebmann, C., Oberdisse, E., Nowak, G.

“…Effects of thrombin on brain cells, including change of neurite outgrowth and astrocyte shape, are described, but the molecular mechanisms are unclear. We…”
Get full text

Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue by Seifert, R, Höer, A, Offermanns, S, Buschauer, A, Schunack, W

“…Human neutrophils and dibutyryl-cAMP (Bt2cAMP)-differentiated HL-60 cells possess receptors for the chemotactic peptide…”
Get more information

PHP30 COST DRIVERS IN THE PHARMACEUTICAL MARKET IN GERMANY IN 2007 by Häussler, B, Höer, A

Get full text

Pain-specific diagnosis patterns in claims data - Identification by means of classification and regression trees (CART) by Schiffhorst, G, Freytag, A, Höer, A, Häussler, B, Gothe, H

“…The identification of beneficiaries with persistent, recurrent or chronic pain in claims data by means of individual diagnoses or analgesic prescription is not…”
Get more information

Identification and grouping of pain patients according to claims data by Freytag, A, Schiffhorst, G, Thoma, R, Strick, K, Gries, C, Becker, A, Treede, R-D, Müller-Schwefe, G, Casser, H-R, Luley, C, Höer, A, Ujeyl, M, Gothe, H, Kugler, J, Glaeske, G, Häussler, B

“…The ICD classification does not provide the opportunity to adequately identify pain patients. Therefore we developed an alternative method for the…”
Get full text